ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 902

High Disease Activity Scores and Leptin Levels in Takayasu Patients with Overweight and Obesity

Gokce Kenar1, Handan Yarkan2, Berrin Zengin1, Gerçek Can2, Merih Birlik1, Nurullah Akkoc1 and Fatos Onen1, 1Rheumatology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey, 2Rheumatology, Dokuz Eylul University Faculty of Medicine, İzmir, Turkey

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Disease Activity, metabolic syndrome, obesity and takayasu arteritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Vasculitis - Poster I: Large Vessel Vasculitis and Polymyalgia Rheumatica

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:  We aimed to determine the prevalence of overweight, obesity and metabolic syndrome (MetS) and leptin levels in patients with Takayasu arteritis (TA) and their associations with disease activity.

Methods:  This cross-sectional study included 32 patients with TA followed up at a Rheumatology clinic of a university hospital. 25 age- and gender-matched patients with systemic lupus erythematosus (SLE) were enrolled as controls. According to the TA follow-up protocol of the Rheumatology and Radiology Board of our hospital, the patients were followed using 3-6 monthly B-mode/Doppler USG examinations and 6-12 monhtly magnetic resonance angiography (MRA). Disease activity was assessed by using the Indian Takayasu Clinical Activity Score 2010-A (ITAS2010-A), radiological activity parameters, and acute-phase reactants (AFR). We used carotid intima media thickness (IMT) measurements and the presence of atheromatous plaques in carotid arteries as indicators of atherosclerosis. We also searched serum leptin and ghrelin levels and their relationship with obesity, overweight and MetS in Takayasu patients.

Results:  32 patients (28 females; mean age: 43 years) who fulfilled the American College of Rheumatology (ACR) criteria for TA were enrolled in this study. The prevalences of overweight (body mass index (BMI) between 25 and 30 kg/m2), obesity (BMI ≥30 kg/m2) and MetS (The National Cholesterol Education Program Adult Treatment Panel III criteria), were 26.5%, 17.6% and 23.5%, respectively. These prevalences were similar in TA and SLE patients. TA patients with obesity/overweight had higher ITAS2010-A scores compared with those without obesity/overweight and those with MetS had higher radiological activity scores compared with those without MetS although they had similar AFR levels. TA patients with obesity/overweight had also higher leptin levels. The frequency of atheromatous plaque was found to be higher in patients with MetS than those without MetS although there was no difference in carotid IMTs between the groups (Table 1).

Conclusion:  This study showed that TA patients had similar prevalences of obesity/overweight and MetS to those found in SLE patients. It also suggested that there was a relationship between disease activity and obesity/overweight and MetS in TA patients. TA patients with greater BMIs had also increased leptin levels.

Table 1. Clinical and laboratory features in Takayasu patients with overweight/obesity and MetS

 

Metabolic syndrome

 

 

P value

 

Overweight and obesity

 

 

P value

 

(+)

(n=8)

 

 

 

(-)

(n=24)

 

(+)

(n=15)

(-)

(n=17)

    ITAS2010-A Active(n)

1

4

>0.05

5

0

0.015*

Inactive(n)

7

20

10

17

  Radiologic activity Active(n)

5

6

0.04*

6

5

>0.05

Inactive(n)

2

17

8

11

CRP (mg/L)

11.5

11.4

>0.05

13.6

9.6

>0.05

ESR (mm/h)

35.0

26.0

>0.05

30.7

27.1

>0.05

Presence of atheromatous plaque (n)  

4

1

0.04*

3

2

>0.05

Leptin (ng/mL)  

58

79

>0.05

100

53

0.05*

Ghrelin (pg/mL)

295

284

>0.05

249

317

>0.05


Disclosure: G. Kenar, None; H. Yarkan, None; B. Zengin, None; G. Can, None; M. Birlik, None; N. Akkoc, None; F. Onen, None.

To cite this abstract in AMA style:

Kenar G, Yarkan H, Zengin B, Can G, Birlik M, Akkoc N, Onen F. High Disease Activity Scores and Leptin Levels in Takayasu Patients with Overweight and Obesity [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/high-disease-activity-scores-and-leptin-levels-in-takayasu-patients-with-overweight-and-obesity/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-disease-activity-scores-and-leptin-levels-in-takayasu-patients-with-overweight-and-obesity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology